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EDITORIAL POLICY AND GENERAL INFORMATION
Reports of Practical Oncology and Radiotherapy
(RPOR) is an interdisciplinary bimonthly journal,
publishing original contributions in clinical oncology
and radiotherapy, as well as in radiotherapy physics,
techniques and radiotherapy equipment. The Journal
is published by Elsevier on behalf of the Polish Society
of Radiation Oncology, the Czech Society of Radiation
Oncology, the Hungarian Society for Radiation
Oncology, the Slovenian Society for Radiotherapy and
Oncology, the Polish Study Group of Head and Neck
Cancer, the Guild of Bulgarian Radiotherapists, the
Portuguese Society of Radiotherapy - Oncology and
affiliated with Spanish Society of Radiotherapy and
Oncology,and Italian Association of Radiotherapy.
These guidelines generally follow the ..Uniform
Requirements for Manuscripts Submitted to
Biomedical Journals " The complete document
appears at http ' /lwww icmje org
Manuscripts should be submitted online at h11u.JL
ees elseviercom/rpor and the instructions on the site
should be closely followed . Authors may submit their
manuscript and track their progress to final decision.
Reviewers can download manuscripts and submit
their report to the editor. All manuscripts are peer
reviewed. Submission of an article implies that the
work described has not been published previously
(except in the form of an abstract or as part of a
published lecture or academic thesis), that it is not
under consideration for publication elsewhere, that
its publication is approved by all authors and tacitly
or explicitly by the responsible authorities where the
work was carried out, and that, if accepted, it will not
be published elsewhere in th e same form, in English
or in any other language, without the written consent
of the copyright-holder.
Editor-in-Chief: Julian Malicki Ph.D., Professor of
the University of Medical Sciences in Poznan, Poland,
Director of Greater Poland Cancer Centre, l S'"
Garbary St. 61-866 Poznan, Poland, Tel: + 48 618850-
700, Fax : +48 618850-801. E-mail: julian.malicki@
wco.pl
EDITORIAL POLICIES
Review process. Manuscripts are evaluated on the
basis that they present new insights to the investigated
topic, are likely to contribute to a research progress
or change in clinical practice or in thinking about a
disease. It is understood that all authors listed on a
manuscript have agreed to its submission.
Received manuscripts are first examined by the
RPOR editors. Manuscripts with insufficient priority
for publication are rejected promptly. Incomplete
manuscripts not prepared in the advised style will
be rejected without scientific review. The registered
manuscripts are sent to independent experts for
scientific evaluation.
Instructions for authors
The evaluation process usually takes 3-4 weeks.
Submitted papers are accepted for publication after a
positive opinion of the independent reviewers.
Permissions. Materials taken from other sources must
be accompanied by a written statement from both
author and publisher giving permission to RPOR for
reproduction. Obtain permission in writing from at
least one author of papers still in press, unpublished
data, and personal communications.
Patients confidentiality. Changing the details of
patients in order to disguise them is a form of data
alteration. However authors of clinical papers
are obliged to ensure patients privacy rights.
Only clinically or scientifically important data are
permitted for publishing. Therefore, if it is possible
to identify a patient from a case report, illustration or
paper, Editors of RPOR ask for a written consent of
the patient or his /her guardian to publish their data,
including photograms prior to publication.
The description of race, ethnicity or culture of a study
subject should occur only when it is believed to be of
strong influence on the medical condition in the study.
When categorizing by race, ethnicity or culture, the
names should be as illustrative as possible and reflect
how these groups were assigned .
Randomised controlled trials. All randomised
controlled trials submitted for publication in RPOR
should include a completed Consolidated Standards of
Reporting Trials (CONSORT) flow chart. Please refer
to the CONSORT statement website at http://www.
consort-statement.org for more information. RPOR has
adopted the proposal from the International Committee
of Medical Journal Editors (ICMJE) which require, as
a condition of consideration for publication of clinical
trials, registration in a public trials registry. Trials must
register at or before the onset of patient enrolment. The
clinical trial registration number should be included at
the end of the abstract of the article. For this purpose,
a clinical trial is defined as any research project that
prospectively assigns human subjects to intervention
or comparison groups to study the cause-and-effect
relationship between a medical intervention and a health
outcome. Studies designed for other purposes, such as
to study pharmacokinetics or major toxicity (e.g. phase
I trials) would be exempt. Further information can be
found at http"!lwww.icmje org .
Ethics. Work on human beings that is submitted to
RPOR should comply with the principles laid down in
the Declaration of Helsinki; Recommendations guiding
physicians in biomedical research involving human
subjects. Adopted by the 18th World Medical Assembly,
Helsinki, Finland, June 1964, amended by the 29th
World Medical Assembly, Tokyo, Japan, October
1975, the 35th World Med ical Assembly, Venice , Italy,
October 1983, and the 41st World Medical Assembly,
Hong Kong, September 1989. The manuscript should
contain a statement that the work has been approved
by the appropriate ethical committees related to the
institution(s) in which it was performed and that
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subjects gave informed consent to the work. Studies
involving experiments with animals must state that
their care was in accordance with institution guidelines.
Patients' and volunteers' names, initials, and hospital
numbers should not be used.
Disclaimer. Every effort is made by the Editor-in-
Chief and the Editorial Board of RPOR to see that no
inaccurate or misleading data, opinion or statement
appear in the Reports of Practical Oncology and
Radiotherapy. However, they wish to make it clear
that the data and opinions appearing in the articles
and advertisements herein are the responsibility of
the contributor, sponsor or advertiser concerned.
Accordingly, the Editor-in-Chief and the Editorial
Board accept no liability whatsoever for the
consequences of any such inaccurate of misleading
data, opinion or statement. Every effort is made
to ensure that drug doses and other quantities are
presented accurately. Nevertheless, readers are
advised that methods and techniques involving drug
usage and other treatments described in RPOR,
should only be followed in conjunction with the drug
or treatment manufacturer's own published literature
in the readers own country.
CRITERIA FOR MANUSCRIPTS
The Editorial Board of Reports of Practical Oncology
and Radiotherapy takes under consideration for
publication original articles with the understanding
that neither the manuscript nor any part of its essential
substance, tables or figures have been published
previously in a print form or electronically and are
not under consideration by any other publication or
electronic medium. This restriction does not apply
to abstracts or press reports published in connection
with scientific meetings. Copies of any closely related
manuscripts should be submitted to the Editor along
with the manuscript that is to be considered by RPOR.
RPOR discourages the submission of more than one
article dealing with related aspects of the same study.
CATEGORIES OF ARTICLES
Accepted papers are published in the following
journal sections:
- original articles (not more than 10 pages)
- review articles (not more than 8 pages)
- preliminary communications for rapid
communication of preliminary data (not more than
4 pages)
- technical notes (not more than 2 pages)
- letters to the Editor for comments on recent
articles (not more than 1 page)
- case reports (not more than 4 pages)
PREPARATION OF MANUSCRIPT
Submission of Articles. All manuscripts should
be written in English. Either American or British
spelling is acceptable, but the form used must be
consistent throughout the article. Authors whose
native language is not English are encouraged to have
their submission checked for spelling and grammar
prior to submission.
The title page should contain the author(s) name
and affiliation. The name of the author will be listed
according to this pattern; given name (or names),
which will be always initialized, followed by the
family name. Please be sure of using this convention
in the submitted paper.
An abstract should be no longer than 250 words and
preferably structured (include aim, briefly materials
and methods, results and conclusion). At the end of
the abstract, key words (not more than four) must
be included to be used for indexing and bibliography
searching. The paper should be subdivided into
sections; typically: Introduction; Theoretical
Background (if applicable); Material and Methods;
Results; Discussion; Conclusions; Acknowledgments
(if applicable); References; Appendix (if applicable) .
Background should contain scientific rationale and
the general introduction to the article.
Aim should clearly describe of the study (in case of a
review) purpose of the article.
Material and methods should describe clearly the
selection of observational or experimental subjects
(patients or laboratory animals) including controls,
such as age, gender, inclusion and exclusion criteria,
(the circumstances for rejection from the study should
be clearly defined) , randomization and masking
(blinding) method.
The protocol of data acquismon, procedures,
investigated parameters, methods of measurements
and apparatus should be described in sufficient detail
to allow other scientists to reproduce the results. Name
and references to the established methods should be
given. References and brief description should be
provided for methods that have been published but
are not well known, whereas new or substantially
modified methods should be described in detail. The
reasons for using them should be provided along with
the evaluation of their limitations. The drugs and other
chemicals should be precisely identified including
generic name, dose and route of administration.
The statistical methods should be described in detail
to enable verification of the reported results.
Provide information on patient's informed consent.
Studies on patients and volunteers require informed
consent documented in the text of the manuscript.Where
there is any unavoidable risk of breach of privacy - e.g.
in a clinical photograph or in case details - the patient's
written consent to publication must be obtained and
copied to the journal. Information on approval of a Local
Ethical Committee should also be provided.
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Results should concisely and reasonably summarize
the findings . Restrict tables and figures to the number
needed to explain the argument of the paper and
assess its support. Do not duplicate data in graphs
and tables. Give numbers of observation and report
exclusions or losses to observation such as dropouts
from a clinical trial. Report treatment complications.
The results should be presented in a logical sequence
in the text, tables and illustrations. Do not repeat in the
text all the data from the tables or graphs. Emphasize
only important observations.
Discussion should deal only with new and/or important
aspects of the study. Do not repeat in detail data or
other material from the Background or the Results
section. Include in the Discussion the implications
of the findings and their limitations, including
implications for future research. The discussion
should confront the results of other investigations
especially those quoted in the text.
Conclusions should be linked with the goals of the
study. State new hypotheses when warranted. Include
recommendations when appropriate. Unqualified
statements and conclusions not completely supported
by the obtained data should be avoided. I
Sections, subsections and sub-subsections are
numbered in Arabic. Major headings should be typed
in bold face; sub-headings in italic; sub-subheadings in
uppercase letters and underlined. Use double spacing
after headings and subheadings. No paragraph after
sub-headings. List of items may be laid with each item
marked by a dot, or numbered with lowercase Roman
numerals or listed with lowercase Roman letters as
in example below: item one item two or i) item one
ii) item two or a) item one b) item two Displayed
equations should be numbered consecutively in
Arabic, with the number set flush right and enclosed
in parentheses.
References. References must be numbered
consecutively as they are cited. References selected
for publication should be chosen for their importance,
accessibility, and for the "further reading"
opportunities they provide. References first cited in
tables or figure legends must be numbered so that
they will be in sequence with references cited in the
text . The style of references is that of Index Medicus.
List all authors when there are six or fewer; when
there are seven or more, list the first three, then "et
al.", The following are sample references:
Standard journal article
Lahita R, Kluger J , Drayer DE et a al : Antibodies to
nuclearantigens in patients treated with procainamide
or acetylprocainamide. N Engl J Med 1979; 301: 1382-
85
Article with published erratum
Koffler D, Reidenberg MM: Antibodies to nuclear
antigens in patients treated with procainamide or
acetylprocainamide [published erratum appears in N
Instruct ions f or aut ho rs
Engl J Med 1979; 302: 322-5]. N Engl J Med 1979;
301: 1382-5.
Article in electronic form
Drayer DE, Koffler D: Factors in the emergence of
infectious diseases. Emerg Infect Dis [seri al online]
1995 Jan-Mar [cited 1996 Jun 5];1(1):[24 screens].
Available from : http://www.cdc .gov/ncidod/EID/eid.
htm.
Article, no author given
Cancer in South Africa [editorial]. S Afr Med J 1994;
84: 15
Book, personal author(s)
Ringsven MK, Bond D: Gerontology and leadership
skills for nurses. 2nd ed. Albany (NY): Delmar
PUblishers; 1996
Book, editor(s) as author
Norman IJ, Redfern SJ, editors: Mental health care
for elderly people. New York: Churchill Livingstone;
1996
Book, Organization as author and publisher
Institute of Medicine (US). Looking at the future of
the Medicaid program. Washington, The Institute,
1992.
Chapter in a book
Phillips SJ , Whisnant JP: Hypertension and stroke.
In: Laragh JH, Brenner BM, editors. Hypertension:
pathophysiology, diagnosis, and management. 2nd ed .
New York, Raven Press, 1995. p. 465-78
Conference proceedings
Kimura J , Shibasaki H, editors: Recent advances
in clinical neurophysiology. Proceedings of the
10th International Congress of EMG and Clinical
Neurophysiology; 1995 Oct 15-19; Kyoto, Japan.
Amsterdam: Elsevier; 1996
Conference paper
Bengtsson S, Solheim BG: Enforcement of data
protection, privacy and security in medical
informatics. In : Lun KC, Degoulet P, Piemme TE,
Rienhoff 0 , editors. MEDINFO 92. Proceedings of the
7th World Congress on Medical Informatics; 1992 Sep
6-10; Geneva, Switzerland.
Avoid using abstracts or review papers as
references. Unpublished observations and personal
communications cannot be used as references.
If essential, such material may be incorporated
in the appropriate place in the text. Tables to be
typed on separate sheets and numbered in order of
mention with Roman numerals. All tables should be
referred to in the text. A caption should be included.
Illustrations to be numbered serially with Arabic
numbers. All figures should be referred to in the
text. Captions should be typed on a separate sheet.
A detailed guide on electronic artwork is available at
Artwork guidelines Artwork must be designed to fit
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either a single column (84 mm wide) or the full text
width of the page (175 mm). Similar images should be
consistent in size . Images should be tightly cropped.
Lettering used in the artwork must be consistent in
size (7-10pt) and font (use Arial, Courier, Helvetica,
Times or Symbol). Figures may be reduced in size for
publication. Mark the appropriate position of a figure
in the article. Number illustrations consecutively in
the order in which they are referred to in the text,
and provide a caption for each figure. Please note :
Because of technical complications which can arise
by converting colour figures to greyscale, please
submit both black and white prints corresponding
to all colour illustrations. Colour artwork will be
published online. '
Electronic Submission of Artwork
- Files must be in the correct format : preferably
TIFF, EPS or MS Office.
- Images should be captured atthe following
minimum resolutions: halftones and colour
(all colour must be RGB) 300 dpi ; combination
halftones 500 dpi ; line art 1000-1200 dpi.
- Annotations to the figure, such as arrows and labels
should be embedded in the electronic file.
- File names should be self-explanatory with file
extension included, e.g. use filename "fig1.tif" for
Figure 1 in TIFF format.
- All illustrations to be provided as separate files.
Acknowledgements. List all contributors who do not
meet the criteria for authorship, such as technical
assistants, writing assistants or head of department
who provided only general support. Financial and
other material support should be disclosed and
acknowledged.
Role of the funding source. All sources of funding
should be declared as an acknowledgement at the end
of the text. Authors should declare the role of study
sponsors, if any, in the study design, in the collection,
analysis and interpretation of data; in the writing
of the manuscript; and in the decision to submit the
manuscript for publication. If the study sponsors had
no such involvement, the authors should so state.
Conflict of interest. At the end of the text, under
a subheading "Conflict of interest statement" all
authors must disclose any financial and personal
relationships with other people or organisations
that could inappropriately influence (bias) their
work . Examples of potential conflicts of interest
include employment, consultancies, stock ownership,
honoraria, paid expert testimony, patent applications/
registrations, and grants or other funding.
Authors of research articles should disclose at the time
ofsubmission any financial arrangement they may have
with a company whose product figures prominently in
the submitted manuscript or with a company making
a competing product. Such information will be held in
confidence while the paper is under review and will
not influence the editorial decision, but if the article
is accepted for publication, the editors will usually
discuss with the authors the manner in which such
information is to be communicated to the reader.
Because the essence of reviews and editorials is
selection and interpretation of the literature, RPOR
expects that authors of such articles will not have any
financial interest in a company (or its competitor) that
makes a product discussed in the article.
RPOR policy requires that reviewers, co-editors,
editorial board members reveal in a letter to the
Editor-in-Chief any relationships that they have that
could be construed as causing a conflict of interest
with regard to a manuscript under review. The
letter should include a statement of any financial
relationships with commercial companies involved
with a product under study.
Manuscripts must be accompanied by a cover letter
signed by the first author. This must include:
1. information on prior or duplicate publication or
submission elsewhere of any part of the work as
defined earlier in this document;
2. a statement of financial or other relationships that
might lead to a conflict of interest;
3. a statement that the manuscript has been read and
approved by all the authors, that the requirements
for authorship as stated earlier in this document
have been met, and that each author believes the
manuscript represents honest work; and
4. the name, address, and telephone number of
the corresponding author, who is responsible
for communicating with the other authors about
revisions and final approval of the proofs.
The letter should give any additional information
that may be helpful to the Editor, such as the type of
article in the particular journal that the manuscript
represents and whether the author would be willing to
meet the cost of reproducing color illustrations. The
manuscript must be accompanied by copies of any
permission to reproduce published material, to use
illustrations or report information about identifiable
people, or to name people for their contributions.
108 REP PRACT ONCOL RADIOTH ER • 2009 • 14/3 / : 105 -109
